PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 2026国际护理与健康0 citationsOpen Access

益肾固精法治疗慢性肾脏病2-3期脾肾气虚型蛋白尿的临床疗效观察

杨杨娟娟

Key Points

  • To explore the clinical efficacy of the Yishen Gujing method in treating CKD stage 2-3 with proteinuria related to spleen and kidney deficiency.
  • Selected 50 CKD stage 2-3 patients with spleen and kidney deficiency from December 2023 to December 2025.
  • Randomly assigned patients to treatment and control groups, each with 25 individuals.
  • The control group received conventional medication, while the treatment group received the Yishen Gujing herbal formula for 12 weeks.
  • The treatment group had a total effective rate of 90.7%, significantly higher than the control group's 72.1% (P < 0.05).
  • The treatment group showed better improvement in traditional Chinese medicine symptom scores compared to the control group (P < 0.05).
  • The treatment group demonstrated a greater reduction in 24-hour urinary protein compared to the control group (P < 0.05).

Abstract

目的:探讨益肾固精法治疗慢性肾脏病(ckd)2-3期脾肾气虚型蛋白尿的临床疗效。方法:选取2023 年12月至2025年12月我院收治的50例慢性肾脏病2-3期脾肾气虚型蛋白尿患者,随机数字表法分为观察组和对照组各 25例。对照组采用常规西药治疗,观察组在对照组基础上加用益肾固精中药汤剂治疗,疗程均为12周。比较两组患 者的中医证候积分、24小时尿蛋白定量变化。结果:治疗后,观察组总有效率为90.7%,显著高于对照组的72.1%(p < 0.05)。观察组在改善中医证候积分、降低24小时尿蛋白定量方面均优于对照组(p < 0.05)。结论:益肾固精法 联合常规治疗能够显著改善慢性肾脏病2-3期脾肾气虚型蛋白尿患者的临床症状,减少蛋白尿,具有良好的临床应用 价值。

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

杨娟娟 (2026) studied this question.

synapsesocial.com/papers/6a192cd5fab5b468c4415b23https://doi.org/10.37155/2717-5650-0702-15
Ask AI
Helpful
Bookmark
Share
View Full Paper